BIOTECNOLOGIA
Departamento
Fundación Jiménez Díaz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (2)
2021
-
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion
Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218
2009
-
Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: Analysis of biological markers in a GEICAM phase II study
Clinical and Translational Oncology, Vol. 11, Núm. 1, pp. 54-59